CD5：从过时的T细胞标志物到免疫疗法的新希望。 - Suppr

CD5: from antiquated T cell marker to immunotherapy's new hope.

作者信息

Schwarz Sandra, Linnebacher Michael

机构信息

Molecular Oncology and Immunotherapy, Clinic of General Surgery, Rostock University Medical Center, 18057, Rostock, Germany.

出版信息

Signal Transduct Target Ther. 2023 May 25;8(1):216. doi: 10.1038/s41392-023-01494-5.

DOI:10.1038/s41392-023-01494-5

PMID:37230972

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10212910/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ba/10212910/38e018f2f00c/41392_2023_1494_Fig1_HTML.jpg

相似文献

CD5: from antiquated T cell marker to immunotherapy's new hope.

Signal Transduct Target Ther. 2023 May 25;8(1):216. doi: 10.1038/s41392-023-01494-5.

Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in vivo.

Arthritis Rheum. 1992 Dec;35(12):1445-51. doi: 10.1002/art.1780351207.

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.

J Hematol Oncol. 2019 May 16;12(1):49. doi: 10.1186/s13045-019-0732-7.

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Cells. 2020 Dec 3;9(12):2589. doi: 10.3390/cells9122589.

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies.

Stem Cell Rev Rep. 2020 Apr;16(2):369-384. doi: 10.1007/s12015-019-09937-9.

Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR).

Clin Exp Immunol. 1997 Jun;108(3):557-61. doi: 10.1046/j.1365-2249.1997.3831280.x.

The Ca2+/calmodulin-dependent kinase type IV is involved in the CD5-mediated signaling pathway in human T lymphocytes.

J Biol Chem. 1997 Dec 12;272(50):31809-20. doi: 10.1074/jbc.272.50.31809.

Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.

Clin Exp Immunol. 1990 Apr;80(1):114-21. doi: 10.1111/j.1365-2249.1990.tb06450.x.

Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy's smart bombs.

Cancer Gene Ther. 2015 Mar;22(2):63. doi: 10.1038/cgt.2015.1.

Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15.

Hum Immunol. 2011 Aug;72(8):627-31. doi: 10.1016/j.humimm.2011.03.028. Epub 2011 Apr 15.

引用本文的文献

Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems.

Mol Ther. 2025 Jan 8;33(1):71-89. doi: 10.1016/j.ymthe.2024.11.024. Epub 2024 Nov 19.

Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.

Cancers (Basel). 2024 Oct 9;16(19):3430. doi: 10.3390/cancers16193430.

Preliminary identification of somatic mutations profile in ACL injury.

Sci Rep. 2024 Oct 1;14(1):22847. doi: 10.1038/s41598-024-73718-9.

A review of CD4 T cell differentiation and diversity in dogs.

Vet Immunol Immunopathol. 2024 Sep;275:110816. doi: 10.1016/j.vetimm.2024.110816. Epub 2024 Aug 21.

Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy.

Front Immunol. 2024 Feb 22;15:1355314. doi: 10.3389/fimmu.2024.1355314. eCollection 2024.

本文引用的文献

CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.

Science. 2023 Feb 17;379(6633):eabg2752. doi: 10.1126/science.abg2752.

Suppressive mechanisms of regulatory B cells in mice and humans.

Int Immunol. 2023 Feb 11;35(2):55-65. doi: 10.1093/intimm/dxac048.

CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.

Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14342-14353. doi: 10.1073/pnas.1922525117. Epub 2020 Jun 8.

Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death.

J Immunol. 2007 Jun 1;178(11):6821-7. doi: 10.4049/jimmunol.178.11.6821.

In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity.

J Immunol. 2005 Jun 1;174(11):6888-97. doi: 10.4049/jimmunol.174.11.6888.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

CD5: from antiquated T cell marker to immunotherapy's new hope.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献